Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335–47.

Article  PubMed  Google Scholar 

Staufer K, Stauber RE. Steatotic liver disease: metabolic dysfunction, Alcohol, or both? Biomedicines. 2023;11(8):2108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su X, Xu J, Zheng C. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes. BMC Endocr Disord. 2019;19(1):76.

Article  PubMed  PubMed Central  Google Scholar 

Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47–64.

Article  PubMed  Google Scholar 

Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542–56.

Article  CAS  PubMed  Google Scholar 

Song SJ, Che-To Lai J, Lai-Hung Wong G, Wai-Sun Wong V, Cheuk-Fung Yip T. Can we use old NAFLD data under the new MASLD definition? J Hepatol. 2024;80(2):e54–56.

Article  PubMed  Google Scholar 

Hagstrom H, Vessby J, Ekstedt M, Shang Y. 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical. J Hepatol. 2024;80(2):e76–77.

Article  PubMed  Google Scholar 

Perazzo H, Pacheco AG, Griep RH. Collaborators. Changing from NAFLD trough MAFLD to MASLD: similar prevalence and risk factors in a large Brazilian cohort. J Hepatol. 2024;80(2):e72–74.

Article  PubMed  Google Scholar 

Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313(22):2263–73.

Article  CAS  PubMed  Google Scholar 

Jakobsen MU, Berentzen T, Sorensen TI, Overvad K. Abdominal obesity and fatty liver. Epidemiol Rev. 2007;29:77–87.

Article  CAS  PubMed  Google Scholar 

Zhao D, Cui H, Shao Z, Cao L. Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease. Ann Hepatol. 2023;28(4):100726.

Article  CAS  PubMed  Google Scholar 

Kouvari M, Polyzos SA, Chrysohoou C, Skoumas J, Pitsavos CS, Panagiotakos DB, et al. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: data from the ATTICA cohort study. Clin Nutr. 2022;41(6):1281–89.

Article  CAS  PubMed  Google Scholar 

Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr. 2014;68(9):1001–07.

Article  CAS  PubMed  Google Scholar 

Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881–87.

Article  CAS  PubMed  Google Scholar 

Cai C, Song X, Chen Y, Chen X, Yu C. Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Hepatol Int. 2020;14(1):115–26.

Article  PubMed  Google Scholar 

Fujii H, Kawada N, Japan Study Group Of Nafld J-N. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int J Mol Sci. 2020;21(11):3863.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia. 2005;48(4):634–42.

Article  CAS  PubMed  Google Scholar 

Severinsen MCK, Pedersen BK. Muscle-organ crosstalk: the emerging roles of Myokines. Endocr Rev. 2020;41(4):594–609.

Article  PubMed  PubMed Central  Google Scholar 

Mirza MS, Obesity V, Fat. Querying the role of Adipokines in the progression of nonalcoholic fatty liver disease. ISRN Gastroenterol. 2011;2011:592404.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo F, Oldoni F, Das A. TM6SF2: a Novel Genetic Player in nonalcoholic fatty liver and Cardiovascular Disease. Hepatol Commun. 2022;6(3):448–60.

Article  CAS  PubMed  Google Scholar 

Luo F, Smagris E, Martin SA, Vale G, McDonald JG, Fletcher JA, et al. Hepatic TM6SF2 is required for Lipidation of VLDL in a Pre-golgi Compartment in mice and rats. Cell Mol Gastroenterol Hepatol. 2022;13(3):879–99.

Article  PubMed  Google Scholar 

Chung GE, Kim MJ, Yim JY, Kim JS, Yoon JW. Sarcopenia is significantly Associated with Presence and Severity of nonalcoholic fatty liver disease. J Obes Metab Syndr. 2019;28(2):129–38.

Article  PubMed  PubMed Central  Google Scholar 

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.

Article  PubMed  Google Scholar 

Seo JY, Cho EJ, Kim MJ, Kwak MS, Yang JI, Chung SJ, et al. The relationship between metabolic dysfunction-associated fatty liver disease and low muscle mass in an asymptomatic Korean population. J Cachexia Sarcopenia Muscle. 2022;13(6):2953–60.

Article  PubMed  PubMed Central  Google Scholar 

Ling CH, de Craen AJ, Slagboom PE, Gunn DA, Stokkel MP, Westendorp RG, et al. Accuracy of direct segmental multi-frequency bioimpedance analysis in the assessment of total body and segmental body composition in middle-aged adult population. Clin Nutr. 2011;30(5):610–15.

Article  PubMed  Google Scholar 

Ogawa H, Fujitani K, Tsujinaka T, Imanishi K, Shirakata H, Kantani A, et al. InBody 720 as a new method of evaluating visceral obesity. Hepatogastroenterology. 2011;58(105):42–4.

PubMed  Google Scholar 

Ballesteros-Pomar MD, Gonzalez-Arnaiz E, Pintor-de-la Maza B, Barajas-Galindo D, Ariadel-Cobo D, Gonzalez-Roza L, et al. Bioelectrical impedance analysis as an alternative to dual-energy x-ray absorptiometry in the assessment of fat mass and appendicular lean mass in patients with obesity. Nutrition. 2022;93:111442.

Article  PubMed  Google Scholar 

Park JH, Lee MY, Shin HK, Yoon KJ, Lee J, Park JH. Lower skeletal muscle mass is associated with diabetes and insulin resistance: a cross-sectional study. Diabetes Metab Res Rev. 2023;39(7):e3681.

Article  CAS  PubMed  Google Scholar 

Yoo JH, Park SW, Jun JE, Jin SM, Hur KY, Lee MK, et al. Relationship between low skeletal muscle mass, sarcopenic obesity and left ventricular diastolic dysfunction in Korean adults. Diabetes Metab Res Rev. 2021;37(1):e3363.

Article  CAS  PubMed  Google Scholar 

Lee YH, Kim SU, Song K, Park JY, Kim DY, Ahn SH, et al. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys (KNHANES 2008–2011). Hepatology. 2016;63(3):776–86.

Article  CAS  PubMed  Google Scholar 

Organization WH. Waist Circumference and Waist-Hip ratio: report of a WHO Expert Consultation. Geneva: World Health Organaization; 2011.

Google Scholar 

Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102(12):2708–15.

Article  PubMed  Google Scholar 

Moon JS, Yoon JS, Won KC, Lee HW. The role of skeletal muscle in development of nonalcoholic fatty liver disease. Diabetes Metab J. 2013;37(4):278–85.

Article  PubMed  PubMed Central  Google Scholar 

Hsing JC, Nguyen MH, Yang B, Min Y, Han SS, Pung E, et al. Associations between Body Fat, muscle Mass, and nonalcoholic fatty liver disease: a Population-based study. Hepatol Commun. 2019;3(8):1061–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim G, Lee SE, Lee YB, Jun JE, Ahn J, Bae JC, et al. Relationship between relative skeletal muscle Mass and nonalcoholic fatty liver disease: a 7-Year longitudinal study. Hepatology. 2018;68(5):1755–68.

Article  CAS  PubMed  Google Scholar 

Zhang X, He Z, Si Q, Hu X, Yang L, Gu X, et al. The Association of Sarcopenia and visceral obesity with lean nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes Mellitus. J Diabetes Res. 2022;2022:2229139.

Article  PubMed  PubMed Central  Google Scholar 

Yan F, Nie G, Zhou N, Zhang M, Peng W. Association of fat-to-muscle ratio with non-alcoholic fatty liver disease: a single-centre retrospective study. BMJ Open. 2023;13(10):e072489.

Article  PubMed  PubMed Central  Google Scholar 

Xing M, Ni Y, Zhang Y, Zhao X, Yu X. The relationship between skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease subtypes in